Thus, our findings do not support a role for CD55 and CD59 in HUS development during EAHEC O104:H4 infection and point to a different mechanism within the complement system for HUS development in EAHEC patients, e.g. secondary phenomena related to profound endothelial and platelet activation or injury. The gene discussed is CD55; the disease is infection.